Literature DB >> 2244641

Late luteal phase dysphoric disorder in young women.

A D Rivera-Tovar1, E Frank.   

Abstract

The authors determined the prevalence of late luteal phase dysphoric disorder in 217 university women aged 17-29 years. Unaware of the focus on premenstrual syndrome (PMS), the participants rated DSM-III-R symptoms of late luteal phase dysphoric disorder over 90 days. Using a 30% or greater premenstrual change as an index of luteal variation, the authors found that 10 women (4.6%) met the symptom criteria during two menstrual cycles. Compared to 25 young women seeking treatment for PMS who met the same diagnostic criteria, the 10 women from the university sample reported significantly less fatigue and impaired concentration and somewhat less severe depression and overall symptoms.

Entities:  

Mesh:

Year:  1990        PMID: 2244641     DOI: 10.1176/ajp.147.12.1634

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  19 in total

1.  Premenstrual dysphoric disorder: burden of illness and treatment update.

Authors:  Teri Pearlstein; Meir Steiner
Journal:  J Psychiatry Neurosci       Date:  2008-07       Impact factor: 6.186

Review 2.  Premenstrual syndrome and premenstrual dysphoric disorder: guidelines for management.

Authors:  M Steiner
Journal:  J Psychiatry Neurosci       Date:  2000-11       Impact factor: 6.186

Review 3.  Premenstrual syndrome. Identification and management.

Authors:  S K Severino; M L Moline
Journal:  Drugs       Date:  1995-01       Impact factor: 9.546

4.  ISPMD consensus on the management of premenstrual disorders.

Authors:  Tracy Nevatte; Patrick Michael Shaughn O'Brien; Torbjorn Bäckström; Candace Brown; Lorraine Dennerstein; Jean Endicott; C Neill Epperson; Elias Eriksson; Ellen W Freeman; Uriel Halbreich; Khalid Ismail; Nicholas Panay; Teri Pearlstein; Andrea Rapkin; Robert Reid; David Rubinow; Peter Schmidt; Meir Steiner; John Studd; Inger Sundström-Poromaa; Kimberly Yonkers
Journal:  Arch Womens Ment Health       Date:  2013-04-27       Impact factor: 3.633

5.  Paroxetine Controlled Release for Premenstrual Dysphoric Disorder: Remission Analysis Following a Randomized, Double-Blind, Placebo-Controlled Trial.

Authors:  Teri B Pearlstein; Kevin M Bellew; Jean Endicott; Meir Steiner
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2005

Review 6.  Role of estrogen in the aetiology and treatment of mood disorders.

Authors:  U Halbreich; L S Kahn
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

7.  The Zurich Study. XIX. Patterns of menstrual disturbances in the community: results of the Zurich Cohort Study.

Authors:  K R Merikangas; M Foeldenyi; J Angst
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1993       Impact factor: 5.270

Review 8.  Reproductive hormone sensitivity and risk for depression across the female life cycle: a continuum of vulnerability?

Authors:  Claudio N Soares; Brook Zitek
Journal:  J Psychiatry Neurosci       Date:  2008-07       Impact factor: 6.186

9.  The prevalence of premenstrual dysphoric disorder in a randomly selected group of urban and rural women.

Authors:  S Gehlert; I H Song; C-H Chang; S A Hartlage
Journal:  Psychol Med       Date:  2008-03-26       Impact factor: 7.723

Review 10.  Update on research and treatment of premenstrual dysphoric disorder.

Authors:  Joanne Cunningham; Kimberly Ann Yonkers; Shaughn O'Brien; Elias Eriksson
Journal:  Harv Rev Psychiatry       Date:  2009       Impact factor: 3.732

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.